Sanctuary Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
FP
Sanctuary Wealth Management's MRNA Position: Q3 2024 in Review
Sanctuary Wealth Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 9 shares — an estimated $1.07K sold.
Sanctuary Wealth Management first reported a position in MRNA in Q4 2022 and held it in 6 quarters. The position peaked at $1.62K in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.
- Sanctuary Wealth Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
- Sanctuary Wealth Management sold 9 Moderna shares in Q3 2024, an estimated $1.07K.
- Sanctuary Wealth Management first reported a position in Moderna in Q4 2022 and held it in 6 quarters.
- Sanctuary Wealth Management's Moderna position peaked at $1.62K in Q4 2022.
- 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.
Based on Sanctuary Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.